Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Cancer Research and Clinical Oncology|February 24, 2020
Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort studyStefano Guadagni, Marco Clementi, Andrew R Mackay, et al.
World Journal of Clinical Oncology|July 3, 2023
Hyperthermia combined with chemotherapy <i>vs</i> chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative studyGiammaria Fiorentini, Donatella Sarti, Andrea Mambrini, et al.
Journal of Cancer Research and Clinical Oncology|October 18, 2019
Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort studyStefano Guadagni, Giammaria Fiorentini, Michele De Simone, et al.
International Journal of Molecular Sciences|November 6, 2020
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase AStefano Guadagni, Antonietta Rosella Farina, Lucia Annamaria Cappabianca, et al.
Antibiotics (Basel, Switzerland)|March 27, 2024
Oral Antibiotics Alone versus Oral Antibiotics Combined with Mechanical Bowel Preparation for Elective Colorectal Surgery: A Propensity Score-Matching Re-Analysis of the iCral 2 and 3 Prospective CohortsMarco Catarci, Stefano Guadagni, Francesco Masedu, et al.
International Journal of Molecular Sciences|November 10, 2017
Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?Stefano Guadagni, Giammaria Fiorentini, Marco Clementi, et al.
BMC Cancer|June 16, 2022
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastasesStefano Guadagni, Francesco Masedu, Giammaria Fiorentini, et al.
International Journal of Molecular Sciences|July 11, 2020
A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian CancerStefano Guadagni, Marco Clementi, Francesco Masedu, et al.
Cells|January 21, 2023
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant MelanomaLucia Cappabianca, Veronica Zelli, Cristina Pellegrini, et al.
Biology|March 27, 2024
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET ProgressionMaddalena Sbaffone, Marie-Lise Jaffrain-Rea, Lucia Cappabianca, et al.
Pageof 9